![j plus](/www.thejakartapost.com/skin/img/jplus/logo.png)
![](/timesofindia.indiatimes.com/toiitpic/2658/images/1/761a88936df81d58ce84384fa5866bb7_0.jpg)
![starbucks in hot water again over racial slur on cup](/i.dailymail.co.uk/i/newpix/2018/05/17/15/4c5c412a00000578-5740807-image-m-5_1526565897132.jpg)
![feedback](/b98584f181.site.internapcdn.net/tmpl/v5/img/1x1.gif)
stephen silberstein, md, director, jefferson university headache center. .
![](/cdn.cnn.com/cnn/.e1mo/img/4.0/logos/menu_entertainment.png)
![science x network](/b98584f181.site.internapcdn.net/tmpl/v5/img/1x1.gif)
1243 Used Today
318 Used Today
80 Used Today
99 Used Today
Discount $10 On Your First Purchases Of $40 Or More
77 Used Today
110 Used Today
323 Used Today
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
stephen silberstein, md, director, jefferson university headache center. .
218 Used Today
200 Used Today